Licaj, Monika
Mhaidly, Rana
Kieffer, Yann http://orcid.org/0000-0003-2722-3071
Croizer, Hugo
Bonneau, Claire http://orcid.org/0000-0001-6251-286X
Meng, Arnaud
Djerroudi, Lounes
Mujangi-Ebeka, Kevin
Hocine, Hocine R.
Bourachot, Brigitte http://orcid.org/0000-0001-7816-0539
Magagna, Ilaria
Leclere, Renaud
Guyonnet, Lea
Bohec, Mylene http://orcid.org/0000-0002-6530-596X
Guérin, Coralie http://orcid.org/0000-0002-1840-4017
Baulande, Sylvain http://orcid.org/0000-0003-3104-1684
Kamal, Maud
Le Tourneau, Christophe http://orcid.org/0000-0001-9772-4686
Lecuru, Fabrice
Becette, Véronique
Rouzier, Roman
Vincent-Salomon, Anne http://orcid.org/0000-0001-5754-5771
Gentric, Geraldine http://orcid.org/0000-0002-7558-8705
Mechta-Grigoriou, Fatima http://orcid.org/0000-0002-3751-6989
Funding for this research was provided by:
Institut National Du Cancer (INCa-DGOS-9963, INCa-11692, INCa_16086, INCa_16101)
Article History
Received: 6 March 2023
Accepted: 29 January 2024
First Online: 12 February 2024
Competing interests
: F.M.-G. received research support from Innate-Pharma, Roche, Fondation Roche and Bristol-Myers-Squibb (BMS). Other authors declare no potential conflict of interest.